Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Wegovy maker Novo Nordisk rebuked by watchdog over failure to disclose payments to UK health groups

Danish drug giant found to have failed to accurately report spending even after admitting to errors

The Guardian - UK · Jan 26, 2025

Novo Nordisk Stock Surges On Weight Loss Drug Data and Analysts Say It's Still a Buy

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight loss drug. Here's what you need to know.

Kiplinger · Jan 24, 2025

Sackler family to pay $6.5 billion for their role in ‘fueling’ opioid epidemic which has killed hundreds of thousands

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved

The Independent UK · Jan 23, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller

The Independent UK · Jan 23, 2025

Sacklers, Purdue To Pay $7.4 Bn Over Opioid Crisis

Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, officials said Thursday.

International Business Times · Jan 23, 2025

Purdue Pharma and Sacklers reach new $7.4bn settlement over opioids crisis

Settlement resolves thousands of lawsuits alleging Oxycontin caused addiction crisis

The Guardian - US · Jan 23, 2025

'It's Out of Control': UnitedHealth Group and Peers Charged Americans 1000% More for Drugs

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

International Business Times UK · Jan 22, 2025

Read news from The Economist, FT, and more,
with one subscription

Medicare Price Negotiations To Continue Under the Trump Administration

The Centers for Medicare & Medicaid Services plans to negotiate the prices for 15 new drugs, although it says its seeking "greater transparency" in price talks.

Kiplinger · Jan 17, 2025

UnitedHealth Is Price Gouging Cancer Patients by Overcharging 'Thousands of Percent' for Live-Saving Meds, Pocketing Extra Billions: Feds

The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases the cost of such medication exponentially.

Latin Times · Jan 16, 2025

3 Niche Biotech Stocks Redefining Innovation

The biotech market offers great investment potential due to innovative advancements in genetic profiling, biologics, CRISPR technology, and rare disease treatments driving strong demand and growth. Therefore, investing in strong biotech stocks like Halozyme Therapeutics (HALO), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR) could be wise. Read on.

StockNews.com · Jan 15, 2025

At last, Britain has a legal drug consumption room – thanks to one man’s civil disobedience

Former heroin addict Peter Krykant set up a safe consumption van during Covid, at great personal cost. But his sacrifice paved the way for real change, says Birkbeck’s Kojo Koram

The Guardian - UK · Jan 15, 2025

Bayer Hit with $100 Million Verdict Over Toxic PCB Exposure

Bayer AG faces a $100 million jury verdict over PCB exposure at a Seattle school amid ongoing legal challenges related to toxic chemicals.

Mic · Jan 15, 2025

Is Aurinia Pharmaceuticals Poised for Growth in the Biotech Space?

Aurinia Pharmaceuticals (AUPH) released its third-quarter results, reporting solid revenue growth and robust cash flow from operations. Solid demand for its product offerings, restructuring strategies, and sound financials remain key drivers of the company’s growth and success. So, let’s analyze whether AUPH is a buy today. Read more to find…

StockNews.com · Jan 14, 2025

‘Positive feedback’ from first users of Glasgow's drugs consumption room

The UK’s first safer drug consumption room has had good uptake and “positive feedback” from users since opening in Glasgow, a minister has…

The National (Scotland) · Jan 14, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard · Jan 14, 2025

‘Positive feedback’ from first users of safer drugs consumption room – minister

Neil Gray said the success of the Thistle Centre would be measured if there are fewer drug deaths and ‘harm reduction’.

The Independent UK · Jan 13, 2025

J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders

Johnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by purchasing Intra-Cellular Therapies

The Guardian - UK · Jan 13, 2025

GSK to buy US cancer drug firm IDRx for up to $1.15bn

Massachusetts-based company is working on new treatments for gastrointestinal cancers

The National (Scotland) · Jan 13, 2025

Scotland's first safe drug consumption room has opened – here's how it works

SCOTLAND’S first safe drug consumption room has officially opened its doors in Glasgow on Monday ...

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK · Jan 12, 2025

From the Beatles to biologics – how Liverpool became a life science hotspot

The city has a long history with tropical medicine and is now home to one of the largest biotech clusters in Europe

The Guardian - US · Jan 10, 2025

Ex-McKinsey partner pleads guilty to destroying records on opioids

Martin Elling pleads guilty to destroying records on advice provided to Purdue Pharma on how to ‘turbocharge’ sales

Evening Standard · Jan 10, 2025

Swinney: Consumption room should help reduce ‘entirely unacceptable’ drug deaths

The First Minister has visited the UK’s first facility where drug users can inject in a clean and safe environment.

The Independent UK · Jan 9, 2025

USTR warns of risks from online pharmacies in its 'notorious markets' report

An annual U.S. government report on “notorious markets” known for counterfeiting and other violations of intellectual property says that nearly all 35,000 online pharmacies around the world are being run illegally

StockNews.com · Jan 8, 2025

3 Blue-Chip Stocks with Strong Buy Ratings from Analysts

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability and long-term growth potential. Thus, one could consider adding these three fundamentally sound blue-chip stocks, AbbVie (ABBV), Merck & Co. (MRK), and Johnson & Johnson (JNJ), with Strong Buy ratings from…

Kiplinger · Jan 8, 2025

Moderna Stock Is Volatile Amid Bird Flu Developments

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know.

The Guardian - UK · Jan 4, 2025

Wegovy maker Novo Nordisk sponsored British pharmacies in pursuit of sales

Danish drug company gave money for Google ads to promote weight loss services and received data on web traffic and prescriptions

1 … 30 31 32 33

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.